Carbocysteines in the current therapy of lung diseases in children

The paper gives information on current mucoactive therapy with carbocysteine for acute and chronic bronchopulmonary diseases. The author’s observations during a multicenter study and the data available in the literature provide evidence that carbocysteine lysine salt (Fluifort) shows high clinical a...

Full description

Bibliographic Details
Main Author: Yu. L. Mizernitsky
Format: Article
Language:Russian
Published: Ltd. “The National Academy of Pediatric Science and Innovation” 2016-11-01
Series:Rossijskij Vestnik Perinatologii i Pediatrii
Subjects:
Online Access:https://www.ped-perinatology.ru/jour/article/view/374
_version_ 1797875314827722752
author Yu. L. Mizernitsky
author_facet Yu. L. Mizernitsky
author_sort Yu. L. Mizernitsky
collection DOAJ
description The paper gives information on current mucoactive therapy with carbocysteine for acute and chronic bronchopulmonary diseases. The author’s observations during a multicenter study and the data available in the literature provide evidence that carbocysteine lysine salt (Fluifort) shows high clinical and immunological efficacies as a mucoregulatory and mucolytic agent used in children aged 2 to 17 years with acute and chronic bronchopulmonary diseases. The highest efficacy of carbocysteine lysine salt has been found in schoolchildren, which is attributable to the age-related features of the formation of the bronchial secretory apparatus and local immune system, as well as in the children with protracted and chronic inflammatory processes, including those associated with smoking.
first_indexed 2024-04-10T01:44:37Z
format Article
id doaj.art-855a50b92db74b608c0e2f947fc3bbfb
institution Directory Open Access Journal
issn 1027-4065
2500-2228
language Russian
last_indexed 2024-04-10T01:44:37Z
publishDate 2016-11-01
publisher Ltd. “The National Academy of Pediatric Science and Innovation”
record_format Article
series Rossijskij Vestnik Perinatologii i Pediatrii
spelling doaj.art-855a50b92db74b608c0e2f947fc3bbfb2023-03-13T09:12:42ZrusLtd. “The National Academy of Pediatric Science and Innovation”Rossijskij Vestnik Perinatologii i Pediatrii1027-40652500-22282016-11-01615192210.21508/1027-4065-2016-61-5-19-22353Carbocysteines in the current therapy of lung diseases in childrenYu. L. Mizernitsky0ОСП «Научно-исследовательский клинический институт педиатрии имени академика Ю.Е. Вельтищева» ГБОУ ВО РНИМУ им. Н.И. Пирогова Минздрава РФ, МоскваThe paper gives information on current mucoactive therapy with carbocysteine for acute and chronic bronchopulmonary diseases. The author’s observations during a multicenter study and the data available in the literature provide evidence that carbocysteine lysine salt (Fluifort) shows high clinical and immunological efficacies as a mucoregulatory and mucolytic agent used in children aged 2 to 17 years with acute and chronic bronchopulmonary diseases. The highest efficacy of carbocysteine lysine salt has been found in schoolchildren, which is attributable to the age-related features of the formation of the bronchial secretory apparatus and local immune system, as well as in the children with protracted and chronic inflammatory processes, including those associated with smoking.https://www.ped-perinatology.ru/jour/article/view/374детимукоактивная терапиямукорегуляторыкарбоцистеина лизиновая сольфлуифорт
spellingShingle Yu. L. Mizernitsky
Carbocysteines in the current therapy of lung diseases in children
Rossijskij Vestnik Perinatologii i Pediatrii
дети
мукоактивная терапия
мукорегуляторы
карбоцистеина лизиновая соль
флуифорт
title Carbocysteines in the current therapy of lung diseases in children
title_full Carbocysteines in the current therapy of lung diseases in children
title_fullStr Carbocysteines in the current therapy of lung diseases in children
title_full_unstemmed Carbocysteines in the current therapy of lung diseases in children
title_short Carbocysteines in the current therapy of lung diseases in children
title_sort carbocysteines in the current therapy of lung diseases in children
topic дети
мукоактивная терапия
мукорегуляторы
карбоцистеина лизиновая соль
флуифорт
url https://www.ped-perinatology.ru/jour/article/view/374
work_keys_str_mv AT yulmizernitsky carbocysteinesinthecurrenttherapyoflungdiseasesinchildren